Antibody-drug conjugates: Intellectual property considerations.

ABSTRACT: Antibody-drug conjugates are highly complex entities that combine an antibody, a linker and a toxin. This complexity makes them demanding both technically and from a regulatory point of view, and difficult to deal with in their patent aspects. This article discusses different issues of patent protection and freedom to operate with regard to this promising new class of drugs.

SUBMITTER: Storz U 

PROVIDER: S-EPMC4966491 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature